HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

starch deferoxamine

biocompatible high molecular weight iron chelators, increase binding capacity to iron and reduce toxicity

Also Known As:

S-DFO

Networked: 7 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Hydroxylamines: 16
    - Hydroxamic Acids: 239
      - Deferoxamine: 2842
        starch deferoxamine: 7
- Carboxylic Acids: 973
  - Hydroxy Acids: 94
    - Hydroxamic Acids: 239
      - Deferoxamine: 2842
        starch deferoxamine: 7

Experts

1.	Al-Jamal, Ola Loay Ahmad: 1 article (03/2019)
2.	Da'as, Sahar: 1 article (03/2019)
3.	Mustafa, Ibrahim: 1 article (03/2019)
4.	Nasrallah, Gheyath K: 1 article (03/2019)
5.	Salem, Rola: 1 article (03/2019)
6.	Scott, Mark: 1 article (03/2019)
7.	Pizanis, A: 1 article (08/2000)
8.	Rose, S: 1 article (08/2000)
9.	Silomon, M: 1 article (08/2000)

Related Diseases

1.	Sepsis (Septicemia) 12/01/1995 - "Protective effects of hydroxyethyl starch-deferoxamine in early sepsis." 07/01/1997 - "Effects of hydroxyethyl starch-deferoxamine on arachidonic acid metabolism and small bowel wall perfusion in early sepsis."
2.	Shock 02/01/1995 - "Attenuation of shock-induced hepatic microcirculatory disturbances by the use of a starch-deferoxamine conjugate for resuscitation." 02/01/1995 - "Rats in the shock groups received either hydroxyethyl starch or a starch-deferoxamine conjugate for resuscitation. " 02/01/1995 - "In contrast, the starch-deferoxamine conjugate improved volumetric blood flow and attenuated leukocyte margination in hepatic sinusoids compared with starch-vehicle, suggesting involvement of iron-dependent, oxygen-derived radicals in shock-induced hepatic microcirculatory disturbances."
3.	Hemorrhagic Shock 08/01/2000 - "Starch-deferoxamine conjugate inhibits hepatocyte Ca2+ uptake during hemorrhagic shock and resuscitation."
4.	Alcoholic Liver Diseases (Alcoholic Liver Disease) 02/01/1997 - "We studied the effect of the long-acting parenteral iron chelator, hydroxyethyl starch deferoxamine (HES-DFO) on liver nonheme iron, lipid peroxidation and pathologic changes in the liver in the intragastric feeding rat model for alcoholic liver disease. "
5.	Body Weight (Weight, Body) 11/01/1994 - "After procurement of the initial bone specimen, 10 dogs received a 10% solution of hydroxyethyl-starch-deferoxamine in 0.9% NaCl (50 mg/kg of body weight, IV), 10 dogs received an equivalent volume (5 ml/kg, IV) of a 10% solution of hydroxyethyl-starch in 0.9% NaCl, and 10 dogs received 0.9% saline solution (5 ml/kg, IV). "

Related Drugs and Biologics

1.	Starch (Cornstarch)
2.	Iron
3.	Oxygen (Dioxygen)
4.	Arachidonic Acid (Vitamin F)
5.	Solutions
6.	Chelating Agents
7.	Saline Solution
8.	hydroxyethyl starch-deferoxamine conjugate
9.	antineoplaston A10 (A 10)

Related Therapies and Procedures

1.	Resuscitation